We continue to add individuals to our editorial board, going to great lengths to reach out beyond the ivory towers of academia to the health care management sector, to research groups within managed care plans, and to the health policy community. We have structured the board to include clinicians, health services researchers, and decision makers, and it is our expectation that with their dedication and hard work our aims will be achieved. In addition to their oversight, we have charged our editorial board members identifying potential authors and assisting us in the peer-review process.
A. Mark Fendrick, MD
Professor of Medicine, School of Medicine
Professor of Health Management and Policy, School of Public Health
Director, Center for Value-Based Insurance Design
University of Michigan
Ann Arbor, MI
Dr Fendrick conceptualized and coined the term value-based insurance design and currently directs the V-BID Center at the University of Michigan, the leading advocate for development, implementation, and evaluation of innovative health benefit plans. His research focuses on how clinician payment and consumer engagement initiatives impact access to care, quality of care, and health care costs. Dr Fendrick has authored more than 250 articles and book chapters and has received numerous awards for the creation and implementation of value-based insurance design. His perspective and understanding of clinical and economic issues have fostered collaborations with numerous government agencies, health plans, professional societies, and health care companies. He is also a member of the Institute for Healthcare Policy and Innovation at the University of Michigan, where he remains clinically active in the practice of general internal medicine.
Michael E. Chernew, PhD
Leonard D. Schaeffer Professor of Health Care Policy
Director, Healthcare Markets and Regulation Lab
Harvard Medical School
Boston, MA
Dr Chernew’s research examines several areas related to improving the health care system including studies of novel benefit designs, Medicare Advantage, alternative payment models, low-value care, and the causes and consequences of rising health care spending.
Dr Chernew is currently serving as the chair of Medicare Payment Advisory Commission (MedPAC) while previously serving as the vice chair from 2012-2014 and a member from 2008-2012. In 2000, 2004, and 2010, he served on technical advisory panels for CMS that reviewed the assumptions used by Medicare actuaries to assess the financial status of Medicare trust funds. He is a member of the Congressional Budget Office’s Panel of Health Advisors and vice chair of the Massachusetts Health Connector Board. Dr Chernew is a member of the National Academy of Sciences, a research associate at the National Bureau of Economic Research, and a senior visiting fellow at MITRE.
Associate Editors
Dennis P. Scanlon, PhD
Pennsylvania State University
University Park, PA
Editorial Board Members
Rena M. Conti, PhD
Boston University
Boston, MA
Rajesh Balkrishnan, PhD
University of Virginia School of Medicine
Charlottesville, VA
Eric Cannon, PharmD, FAMCP
SelectHealth
Murray, UT
Jeffrey D. Dunn, PharmD, MBA
Cooperative Benefits Group
Salt Lake City, UT
William E. Encinosa, PhD
Agency for Healthcare Research and Quality
Rockville, MD
Dana P. Goldman, PhD
University of Southern California
Los Angeles, CA
Inmaculada Hernandez, PhD, PharmD
University of California, San Diego
San Diego, CA
Christine Juday, MPH
Real Chemistry
Grand Rapids, MI
Tracy A. Lieu, MD, MPH
Kaiser Permanente Northern California
Oakland, CA
David Mirkin, MD
Milliman
New York, NY
Joshua J. Ofman, MD, MSHS
GRAIL, Inc
Menlo Park, CA
Scott D. Ramsey, MD, PhD
Fred Hutchinson Cancer Center
Seattle, WA
Dean G. Smith, PhD
Louisiana State University Health Sciences Center
New Orleans, LA
Erin Trish, PhD
University of Southern California
Los Angeles, CA
Jan E. Berger, MD, MJ
Health Intelligence Partners
Northbrook, IL
Mona M. Chitre, PharmD
Excellus BlueCross BlueShield
Rochester, NY
Stacie B. Dusetzina, PhD
Vanderbilt University
Nashville, TN
Austin Frakt, PhD
Department of Veterans Affairs
Boston University
The Incidental Economist
Boston, MA
Clifford S. Goodman, PhD
The Lewin Group, Inc
Falls Church, VA
Richard A. Hirth, PhD
University of Michigan
Ann Arbor, MI
Charles N. Kahn III, MPH
Federation of American Hospitals
Washington, DC
Ariel Linden, DrPH
Linden Consulting Group
San Francisco, CA
Elizabeth Mitchell
Purchaser Business Group on Health
San Francisco, CA
Kavita K. Patel, MD, MSHS
Brookings Institution
Bethesda, MD
Cary Sennett, MD, PhD
Institute for Functional Medicine
Washington, DC
Sarah A. Spinler, PharmD
Binghamton University
Binghamton, NY
Daniel B. Wolfson, MHSA
ABIM Foundation
Philadelphia, PA
Steven J. Bernstein, MD, MPH
University of Michigan
Ann Arbor, MI
Jonas de Souza, MD, MBA
HCA Healthcare
Nashville, TN
Jennifer Elston Lafata, PhD
University of North Carolina
Chapel Hill, NC
Alan M. Garber, MD, PhD
Harvard University
Cambridge, MA
Ryan Haumschild, PharmD, MS, MBA
Emory Healthcare and Winship Cancer Institute
Atlanta, GA
Sachin H. Jain, MD, MBA
SCAN Group and SCAN Health Plan
Long Beach, CA
Harlan M. Krumholz, MD
Yale University
New Haven, CT
J. Michael McWilliams, MD, PhD
Harvard Medical School
Boston, MA
John M. O’Brien, PharmD, MPH
National Pharmaceutical Council
Washington, DC
Hoangmai (Mai) Pham, MD, MPH
Independent Consultant
Washington, DC
Bruce Sherman, MD, FCCP, FACOEM
Cone Health/Triad HealthCare Network
Case Western Reserve University
School of Medicine
Greensboro, NC
Glen Stettin, MD
Express Scripts
St Louis, MO